GlassScriptPhysician profile
Richard L Rupp
NPI 1619956489
$630.86
in general payments reported to CMS, 2019-2025
10 companies · $21.85 in 2025
The $21.85 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.96 · 2020: $46.21 · 2022: $315 · 2023: $51.85 · 2024: $178 · 2025: $21.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $143.69 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $118.46 | 2022 | |
| Bioventus LLC | $87.32 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $72.28 | 2022-2024 | Collagenase Santyl |
| Angiodynamics, INC. | $62.69 | 2022 | |
| Paratek Pharmaceuticals, INC. | $47.77 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $46.21 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.95 | 2022 | |
| Linvatec Corporation | $17.96 | 2019 | |
| Abbott Laboratories | $14.53 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Rupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.